The COVID-19 pandemic has illustrated how today’s health care environment and current delivery models are ill-equipped to adequately address community health and public safety. This Project Santa Fe Foundation thought leadership publication proposes an advanced role for the clinical laboratory as a key partner for population health management, health outcomes, and public safety.

Please flip through the below document. If you would like to download a printable version, fill out the form at the bottom of this page.

If you would like a printable version of the whitepaper, please fill out the below form. You will receive an email with a link to download the printable document.

    AUTHORS:

    Khosrow R. Shotorbani, MBA, MT (ASCP)
    President/Executive Director Project Santa Fe Foundation
    Founder, CEO Lab 2.0 Strategic Services, LLC
    Salt Lake City, UT
    Khosrow.shotorboni@me.com

    Kathleen M. Swanson, MS, RPh
    Manager, CL 2.0 Demonstration Projects
    Faculty, Project Santa Fe Foundation
    Albuquerque, NM
    Kathleen.swanson1@outlook.com

    Mark K Fung, MD PhD
    Board of Directors, Project Santa Fe Foundation
    Vice Chair for Research, Pathology and Laboratory Medicine
    University of Vermont Medical Center
    Burlington, VT 05401
    Mark.Fung@uvmhealth.org

    Jill Warrington, MD, PhD
    Director for Population Health, Pathology and Laboratory Medicine
    Larner College of Medicine, University of Vermont
    Chief Scientific Officer, Averhealth
    Laboratory Director, Vermont Department of Health Laboratory
    Burlington, VT
    jwarrington@averhealth.com

    Beth Bailey
    Faculty, Project Santa Fe Foundation
    Director, Strategic Development and Communications
    TriCore Reference Laboratories
    Albuquerque, NM
    beth.bailey@tricore.org

    Michael J Crossey, MD, PhD
    Board of Directors, Project Santa Fe Foundation
    Chief Medical Officer
    TriCore Reference Laboratories
    Albuquerque, NM
    michael.crossey@tricore.org